Learning Objectives
At the conclusion of this activity, participants should be able to:
- 1. Evaluate the evidence behind three common emergency medicine pharmacotherapy practices: opioid-nausea prophylaxis, “B52” chemical restraint, and refractory migraine management.
- 2. Recommend evidence-based pharmacologic strategies for nausea, acute agitation, and refractory migraine in the emergency department.
- 3. Evaluate patients with toxicologic exposures, hazmat incidents, and disaster-related emergencies.
- 4. Select appropriate pharmacologic and supportive strategies for toxicologic or mass-casualty emergencies.
Faculty
Daniel P. Hays, PharmD, BCPS, FASHP
Clinical Pharmacy Specialist, UMC of Southern Nevada
David P. Huhtelin, PharmD, BCCCP, BCEMP
PGY2 Emergency Medicine Pharmacy Residency Program Director, UW Health Swedish American Hospital, Rockford, Illinois
Faculty Disclosure:
Dr. Hays and Dr. Huhtelin have no relevant financial relationships with ineligible companies to disclose.
Planner Disclosure:
The planners and content reviewers for this activity have no relevant financial relationships with ineligible companies to disclose. All individuals in a position to control the content of this activity have disclosed their relevant financial relationships. No relevant financial relationships were identified.
CPE Credit
Pharmacy Pearls LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0683-9999-26-031-H01-P | 0.10 CEUs / 1.0 Contact Hour
Activity Type: Knowledge-based
Target Audience: Pharmacists
Home Study Format: Web-based (empharmacists.org/courses)
Release Date: 06/03/2026
Expiration Date: 06/03/2028
Joint Providership: Society of Emergency Medicine Pharmacists (SEMP)
To obtain 1.0 contact hour of continuing pharmacy education credit (0.1 CEU), participants must complete the on-demand presentation, pass the post-activity assessment with a minimum score of 80%, and complete the activity evaluation. Once successfully completed, the CPE Statement of Credit can be accessed on CPE Monitor at www.MyCPEMonitor.net.
Activity Description
This continuing education activity features two case-based presentations from emergency medicine pharmacists and residents covering evidence-based pharmacotherapy practices in the emergency department, including opioid-induced nausea prophylaxis, “B52” chemical restraint, and refractory migraine management, as well as the evaluation and management of toxicologic exposures, hazmat incidents, and disaster-related emergencies. Each case emphasizes critical thinking, evidence-based decision making, and practical clinical pearls to support optimal patient care in high-acuity emergency medicine settings.